Cell kinetic parameters were measured in four cases of meningioma showing regrowth. The cell cycle time (T<SUB>c</SUB>) and tumor doubling time (T<SUB>d</SUB>) were established by histological evaluation of the biopsy speci mens and calculation of the growth curve based on computed tomography (CT)/magnetic resonance (MR) images. MIB-1 mouse monoclonal antibody, which recognizes an epitope of the Ki-67 antigen, was used to establish the MIB-1 staining index (SI) (MIB-1-positive nuclei/5000 tumor cells) for each tumor. The changes in tumor volume were calculated from CT/MR images, and the T<SUB>d</SUB> was estimated from the growth curve. The T<SUB>c</SUB> was calculated using Steel's formula from the MIB-1 SI and tumor volume. MIB-1 SI varied from 0.0055 to 0.0468, T<SUB>d</SUB> from 270 to 1429 days, and T<SUB>c</SUB> from 10.4 to 15.9 days. Furthermore, the potential doubling time (T<SUB>p</SUB>) was calculated using the corresponding T<SUB>c</SUB> and MIB-1 SI (growth frac tion) for the four cases; these values varied from 197 to 1645 days and were very close to the T<SUB>d</SUB> values. This method of evaluation of tumor T<SUB>c</SUB> and calculation of T<SUB>p</SUB> may be useful for predicting the postopera tive course in meningiomas.
Introduction
Tumor biological behavior and progression are close ly related to the cell kinetic parameters of the neo plastic cells. Data for such parameters in meningio mas refer mainly to tumor doubling time (Td) 3,11,12) and to potential doubling time (Tp).9,17) Since tumor regrowth is not uncommon after incomplete resec tion of meningiomas, accurate evaluation of cell ki netic parameters employing biopsy specimens may establish the natural course of the tumor more clear ly and help to determine the timing of reoperation on the residual tumor.
Ki-67 monoclonal antibodies (mAbs) react with a human nuclear antigen expressed in all proliferating and dividing cells during all active parts of the cell cycle .6) Therefore, Ki-67 mAbs have been used to esti mate the growth fraction (GF) of various types of brain tumors.1,4,7,14-ls,zl,zz)
The present study evaluated the GF in four menin giomas using MIB-1 mAb, a recently developed Ki 67 mAb,z) calculated the tumor size and growth rates based on analysis of neuroimaging, and established the cell cycle time (Ta) and Td.
Materials and Methods

I. Patients
During the past 10 years, 136 patients with menin gioma have been treated at the Department of Neu rosurgery in Kyoto Prefectural University of Medi cine and Matsushita Memorial Hospital. Among these 136 patients, 36 underwent incomplete resec tion of the tumor (exceeding Simpson's surgical grade 3).18) Six residual tumors showed regrowth on computed tomography (CT) or magnetic resonance (MR) imaging. Four of these six meningiomas were examined in the present study.
II. MIB-1 staining index (SI)
Routine histological examination and immuno histochemistry were performed on biopsy speci mens from the four patients. Immunohistochemical staining used the streptavidin/peroxidase method (Dako StreptABComplex/HRP Duet mouse/rabbit kit; Dako Co., Santa Barbara, Cal., U.S.A.), and MIB Germ any), which recognizes an epitope of the Ki-67 anti gen. 13)
Five thousand tumor cell nuclei in 8 to 12 random ly selected high-power fields (x 400) were counted for each specimen. Endothelial cells were excluded from the counting. The MIB-1 SI (MIB-1-positive nuclei/5000 tumor cells) was calculated for each tumor.
III.
Growth curve from CT/MR images Tumor volume was calculated from CT/MR im ages using a slide scanner and Image 1.44 (National Institutes of Health, Bethesda, Md., U.S.A).5) The Image 1.44 program analyzes scanned images of CT/ MR images and measures the size of the regions of interest (in cm2). The areas of contrast enhancement were measured in each segmented image. The volume of the tumor (in cm3) was calculated by mul tiplying by the slice thickness. The tumor volume was calculated at several time points after the opera tion. The growth curve of the tumor was drawn us ing simple linear regression analysis.
IV.
Calculation of T, and Td T, was calculated by Steel's formula") based on the following assumptions.
In general, when all cells of the tumor are actively dividing and cell loss is negligible, the cell popula tion of the tumor at time point t (Nt) is given by the following equation:
where N0 is initial tumor cell population. 
where b is the growth constant. This equation is analogous to Equation (1) . In the interval of one cell cycle time (t = Ta), the equation can be rewritten as follows using the GF of the tumor:
and therefore
When t is TP, Nt will be double the initial population (from the definition of TP):
and b = loge2/Tp (8)
From Equations (6) and (8), TP can be calculated by the following equation:
In the present study, GF was given by MIB-1 SI.
Although the actual T, of meningioma in situ is unknown, the calculated Tc in each case was em ployed in the present study. Using the range of Tc for the four cases in this study and the MIB-1 SI in each case, the TP was estimated for each case.
Results Table 1 summarizes the cell kinetic parameters and relevant clinical data.
Case 1: A 31-year-old female was admitted to our hospital because of headaches. Partial removal of a large falcotentorial meningioma was performed on June 21, 1990. After surgery, the calculated tumor volume was 14.4 cm3 (V0), and 1233 days (t) later, had reached 27.6 cm3 (Vt). The MIB-1 SI of the surgical specimen was 0.0055 (GF). The calculated T, derived from these values was 10.4 days. on August 7, 1986, for a falx meningioma. The MIB 1 SI of the tumor was 0.018 (GF). After surgery, con tinuous growth of the tumor was seen. The initial tumor volume was 11.6 cm3 (V0), and had become 24.6 cm3 (Vt) 672 days (t) later. The T, calculated from these values was 15.9 days. Figure 2 shows the CT/MR images of the tumor and its growth curve. The relationship between tumor volume (Y) and time (X) is given by Y = 11.6 + 0.0194X. The Td directly measured by this relationship was 619 days. Case 3: A 26-year-old male was admitted because of a focal seizure of the left leg. Subtotal removal of a right falx meningioma was performed on May 10, 1990. The tumor volume after removal was 2.0 cm3 (V0), and had increased to 6.5 cm3 (Vt) 407 days (t) later. The MIB-1 SI of the tumor was 0.0468 (GF).
From these values, the T, was calculated as 15 .7 days. 
Discussion
Previously, measurement and evaluation of cell ki netic parameters in meningiomas has used two ap proaches: retrospective measurement of Td from the growth curve based on CT/MR images3'11,12); and cal culation of the tumor Tp using a double labeling method (bromodeoxyuridine and iododeoxyuridine) based on a mathematical model of cell prolifera tion .9'17) The importance of evaluating the Td in menin giomas was stressed, because the Td has been consi dered as useful for predicting the natural course in individual patients. The Td calculated for cases of benign meningioma has been reported as ranging from 138 to 1045 days (mean 415 days) '12) 159 to 440 days 3) and 197 to 7943 days.") The range of Td in our study varied from 270 to 1429 days. The Td is the actual tumor doubling time calculated from retrospective analysis of CT/ MR images, so correlates with the natural course of the tumor. However, Td cannot be used to predict the natural course of the residual tumor just after the operation.
Study of a series of human malignant glial tumors using [3H]thymidine suggested that the biological be havior and prognosis were closely related to the GF of each tumor and not to the Tc.10) Recently, T, has been found to differ according to the histological type of the neoplastic cells. For example, the Tc in glioblastomas is shorter than that in malignant or in differentiated astrocytomas.16) Therefore, the proliferation activity of glioma may depend on Ti as well as on GF, and knowledge of the exact value of Tc may be important for the planning of adjuvant postoperative therapy.
The present study evaluated the Ti based on the tumor volume calculated from the CT/MR images (clinical data) and from the MIB-1 SI (pathological data). We assumed that the cell loss in the meningio ma is negligible when using Steel's formula for cal culating TC.19) Unlike malignant gliomas, necrosis is not commonly seen in meningioma. Therefore, cell loss in meningioma is lower than in malignant glio mas. The range of calculated Tc in this study varied from 10 to 16 days. The objective of calculating the range of Tc was to estimate Tp and therefore to predict the behavior of the residual tumor just after the operation. Using the range of T,, Tp can be calcu lated from the MIB-1 SI of surgical specimens. In all our cases, the value of TP (the theoretical doubling time) was found to be quite close to that of Td (the ac tual doubling time). Therefore, such an estimation of TP in meningiomas is fairly reliable. Accurate evalua tion of the range of T, in situ based on data from many cases is necessary. Measurement of MIB-1 SI in individual patients will become of major impor tance for the planning of postoperative therapy. TP Since the measurement of Td requires a retrospec tive analysis of tumor growth, the evaluation of TP is essential for the prediction of the natural course of meningiomas.
The present study included very few cases, but the method described for the evaluation of Tc and Tp is very simple and reliable and potentially very useful for establishing the clinical prognosis and planning adjuvant treatment for patients with residual meningioma. Commentary Nakagawa et al. present four cases (2 female, 2 male) of recurrent meningioma after incomplete resection exceeding Simpson's grade 3. Cell kinetic parameters were measured using MIB-1 staining index and growth curves from CT-MR images. They state that their method of determining cell-cycle time and tumor doubling time may be useful for predicting the postoperative course in meningiomas. This state ment, based on only four cases, is not new. In 1993 Black') highlighted the present status of the biology of meningiomas. The postoperative course can be predicted using the WHO classification and the Sim pson classification which shows recurrence rates for grades III and IV of 29% and 40%, respectively. As another useful predictor of recurrence, flow-cytomet ry has been suggested.2) The management of meningio mas is still a surgical challenge since the days of Har vey Chshing, even with the knowledge of the molecu lar biology of these tumors gained during the last years.
